Rohto Pharmaceutical Co.,Ltd. (TYO:4527)
Japan
· Delayed Price · Currency is JPY 2,033.50
-13.50 (-0.66%)
Jun 27, 2025, 3:30 PM JST
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2016 - 2018 |
Skin Care | 176.82B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Skin Care Growth | 12.87% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Eye Care | 53.40B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Eye Care Growth | 10.84% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Oral Medication | 30.90B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Oral Medication Growth | 16.21% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 9.72B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 34.34% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 9.72B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 34.34% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2016 - 2018 |
Other | 2.79B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 19.21% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Japan | 156.85B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Japan Growth | 14.77% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia | 78.75B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia Growth | 11.27% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
America | 18.57B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
America Growth | 11.47% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe | 13.88B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe Growth | 13.51% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 2.79B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 19.21% |
Log In |
Log In |
Log In |
Log In | Upgrade
|